Evinacumab clinical trials
Also written REGN1500 and Evkeeza™.
How each study uses evinacumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 11 Feb 2021 · EVKEEZA · BLA 761181 (FDA, Drugs@FDA)
- European Union
- 17 Jun 2021 · Evkeeza · EMEA/H/C/005449 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
11 studies that test it; most in 2018 (3)
| Year | Studies |
|---|---|
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 10 · Other 1
Regeneron Pharmaceuticals (10) · Daniel Gaudet (1)
Studies
Open first, then newest update. How each study uses evinacumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 11
- Evaluate the Long-Term Safety and Efficacy of Evinacumab in Patients With Homozygous Familial HypercholesterolemiaCompletedPhase 3Regeneron PharmaceuticalsNCT03409744Written as evinacumab
- Safety and Effectiveness of Evinacumab for the Treatment of Homozygous Familial HypercholesterolemiaCompletedPhase 3Daniel GaudetNCT05611528Written as Evinacumab
- Evaluate the Efficacy and Safety of Evinacumab in Pediatric Patients With Homozygous Familial HypercholesterolemiaCompletedPhase 3Regeneron PharmaceuticalsNCT04233918Written as Evinacumab
- Efficacy and Safety of Evinacumab in Adult Patients With Severe Hypertriglyceridemia for the Prevention of Recurrent Acute PancreatitisTerminatedPhase 2Regeneron PharmaceuticalsNCT04863014Written as evinacumab
- Safety and Efficacy Following Repeat-Dose of Evinacumab (Anti-ANGPTL3) in Patients With Severe Hypertriglyceridemia (sHTG) at Risk for Acute PancreatitisCompletedPhase 2Regeneron PharmaceuticalsNCT03452228Written as evinacumab
- Study of Evinacumab (REGN1500) in Participants With Persistent HypercholesterolemiaCompletedPhase 2Regeneron PharmaceuticalsNCT03175367Written as Evinacumab
- Efficacy and Safety of Evinacumab in Patients With Homozygous Familial HypercholesterolemiaCompletedPhase 3Regeneron PharmaceuticalsNCT03399786Written as evinacumab
- Study of REGN1500 in Participants With Homozygous Familial Hypercholesterolemia (HoFH)CompletedPhase 2Regeneron PharmaceuticalsNCT02265952Written as REGN1500 250 mg SC/15 mg/kg IV/450 mg SC
- Study of Evinacumab (REGN1500) in Caucasian and in Japanese Healthy VolunteersCompletedPhase 1Regeneron PharmaceuticalsNCT03146416Written as Evinacumab
- Study to Assess the Safety and Tolerability of Single Doses of REGN1500CompletedPhase 1Regeneron PharmaceuticalsNCT01749878Written as REGN1500
- Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1500CompletedPhase 1Regeneron PharmaceuticalsNCT02107872Written as REGN1500
Given beside what is tested · 1 — evinacumab is usual care or a partner of the new treatment
Codes
What other systems call evinacumab · ClinicalTrials.gg INT000744
- MeSH (NLM) C000621590evinacumabConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) T8B2ORP1DWEVINACUMABConfirmed FDA, NLM, Wikidata
- RxNorm 2478335One source FDA
- Wikidata Q19904115evinacumabConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C169973EvinacumabOne source FDA
- DrugBank DB15354One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000621590 | evinacumab | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | T8B2ORP1DW | EVINACUMAB | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2478335 | — | One source FDA |
| Wikidata | Q19904115 | evinacumab | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C169973 | Evinacumab | One source FDA |
| DrugBank | DB15354 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.